GP9

GP9 Full Name

glycoprotein IX (platelet)

GP9 Introduction

Glycoprotein IX (GP9) is a critical component of the platelet-specific GPIb-IX-V complex, which plays a central role in hemostasis and vascular integrity. GP9 is primarily expressed on the surface of platelets and megakaryocytes, serving as a key adhesion receptor that mediates platelet binding to von Willebrand factor (vWF) under high shear stress conditions. Recent single-cell transcriptomic studies have shown that GP9 expression is significantly upregulated during the differentiation of megakaryocyte progenitors into platelet-producing cells and remains stable in mature platelets. This highlights GP9 not only as an essential player in platelet function but also as a marker of megakaryocyte maturation, providing valuable insight for researchers exploring platelet biogenesis and regenerative therapies.

Beyond its classical role in blood clotting, GP9 has emerged as a multifaceted regulator at the intersection of coagulation and immune responses. Evidence indicates that GP9 and the GPIb-IX-V complex contribute to immune surveillance and inflammation by modulating platelet interactions with leukocytes and the vascular endothelium. GP9's transmembrane and intracellular signaling domains are crucial for platelet adhesion under dynamic flow, especially at sites of vascular injury or atherosclerotic plaque rupture. These findings suggest that GP9 could serve as a potential therapeutic target not only in thrombosis but also in inflammatory and cardiovascular diseases, making it highly relevant for translational research in hemostasis and immunology.

Clinically, mutations or deficiencies in GP9 are directly associated with bleeding disorders, most notably Bernard-Soulier Syndrome, characterized by macrothrombocytopenia and impaired platelet function. Beyond hereditary bleeding syndromes, GP9's involvement in platelet clearance, thrombopoietin regulation, and tumor-platelet interactions indicates its broader impact on disease progression, including cancer metastasis. Emerging studies highlight that targeting GP9-mediated pathways may offer novel strategies for controlling platelet-related pathologies while minimizing adverse bleeding risks, positioning GP9 as both a biomarker and a promising therapeutic target in hematology and oncology research.

Alternate Names for GP9

GP9; glycoprotein IX (platelet); GPIX; CD42a; platelet glycoprotein IX; glycoprotein 9;

• 1.Srivastava P, et al.; scMaSigPro: Differential Expression Analysis along Single-Cell Trajectories. Bioinformatics. 2024, 40(7):btae443.
  2.Bendas G, Schlesinger M. The GPIb-IX complex on platelets: insight into its novel physiological functions affecting immune surveillance, hepatic thrombopoietin generation, platelet clearance and its relevance for cancer development and metastasis. Exp Hematol Oncol. 2022, 11(1):19.